Overholt B F, Panjehpour M
Laser Department, Thompson Cancer Survival Center, Knoxville, Tennessee, USA.
Gastrointest Endosc Clin N Am. 1997 Apr;7(2):207-20.
In summary, in a group of 55 patients with Barrett's esophagus and dysplasia, the authors have reported the ablation of seven superficial cancers, the elimination of dysplasia in 42 of the 55 patients, the complete elimination of Barrett's mucosa in 16 patients, and the reduction of the extent of Barrett's mucosa in all patients who were treated with PDT and were maintained on long-term omeprazole. Repeated PDT sessions were required in some patients to accomplish elimination of dysplasia. Esophageal strictures occurred in 53% of patients, but were treated satisfactorily with dilation. Current results using 5- and 7-cm centering balloons has shown a dramatic reduction in the incidence of stricture formation. Mucosal injury with these balloons is less than with diffusers or shorter balloons that require overlapping of treated areas. The authors are carefully following the patients treated with longer PDT balloons to evaluate the long-term effects on dysplasia. Lugol's staining is an important technique to identify residual patches of Barrett's mucosa following PDT. Small residual patches of Barrett's mucosa can be successfully destroyed with Nd: YAG laser therapy. The authors' results indicate that PDT alone or in combination with thermal ablation can eliminate superficial cancers, dysplasia, and Barrett's mucosa in many patients with Barrett's esophagus.
总之,在一组55例患有巴雷特食管和发育异常的患者中,作者报告了7例浅表癌的消融、55例患者中42例发育异常的消除、16例患者巴雷特黏膜的完全消除,以及所有接受光动力疗法(PDT)并长期服用奥美拉唑的患者中巴雷特黏膜范围的缩小。部分患者需要重复进行PDT疗程以实现发育异常的消除。53%的患者发生了食管狭窄,但通过扩张治疗效果良好。目前使用5厘米和7厘米中心球囊的结果显示狭窄形成的发生率显著降低。与扩散器或需要重叠治疗区域的较短球囊相比,这些球囊造成的黏膜损伤更小。作者正在密切关注接受更长PDT球囊治疗的患者,以评估对发育异常的长期影响。卢戈氏染色是识别PDT后巴雷特黏膜残留斑块的一项重要技术。巴雷特黏膜的小残留斑块可以通过钕钇铝石榴石激光疗法成功消除。作者的结果表明,单独使用PDT或与热消融联合使用,可以消除许多巴雷特食管患者的浅表癌、发育异常和巴雷特黏膜。